In order to help vitiligo patients find and enroll in clinical trials, this page lists all clinical trials that are known to be open to vitiligo patients. Before enrolling in a clinical trial it is important to understand the potential risks and benefits, and to discuss your options with your dermatologist.
There is a number of funded projects in Australia, Austria, Brazil, Canada, France, Netherlands, Spain, Taiwan, Thailand that are currently looking for participants:
- Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment. By Medical University of Graz. Active, but not recruiting patients. Start date: February 2008. External link
- Long-term Follow-up in Patients Affected With Acrofacial Vitiligo. By Irmandade da Santa Casa de Misericordia de Curitiba. Recruiting patients. Start date: August 2010. External link
- Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo. By University of British Columbia. Recruiting patients. Start date: January 2013. External link
- Efficacy of Red Light in Vitiligo. By University of British Columbia. Recruiting patients. Start date: February 2013. External link
- NB-UVB + placebo vs. NB-UVB + lipoic acid tablets for the treatment of the sporadic treatment quiescent vitiligo: efficacy and safety of the multi-center, randomized, double-blind, parallel-group clinical trials. By The First Hospital of China Medical University. Start date: September 2012. External link
- Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis). By University Hospital, Ghent. Start date: February 2010. External link
- Exploratory Study To Evaluate the Safety and Efficacy of CD07387 Solution In Patients With Vitiligo. By Galderma R&D. Recruiting patients. Start Date: February 2010. External Link
- Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo. By Centre Hospitalier Universitaire de Nice. Recruiting patients. Start date: May 2011. External link
- Double-blind, randomized study to evaluate the ability of H-009 and Arsenic-sulphuricum-flavum in stimulating pigmentation in vitiligo and examining safety in patients. By Life Force Homeopathy. Recruting patients. Start date: March 2012. External link
- Pharmaceutical standardization of two different dosage form of Apamarg Kshara Yoga and Their clinical efficacy on Shvitra (vitiligo). By Department of RS BK I P G T and R A Gujarat Ayurved University. Not recruiting patients. Start date: November 2012. External link
- Comparative efficacy of 0.1%Tacrolimus ointment versus 0.005% Calcipotriol ointment in perifollicular pigmentation in patients with hand and facial vitiligo. By Sina Hospital. Start date: June 2012. External link
- Narrow band UV-B phototherapy and fluticasone proprionate versus narrow band UV-B phototherapy and placebo for the treatment of active vitiligo: a randomized double blind controlled trial. By Academic Medical Center. Recruiting patients. Start date: July 2009. External link
- Punchgrafting Techniques for Vitiligo (MiniSNIP). By Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). Recruiting patients. Start date: June 2011. External link
- Ensayo clínico fase I-II, controlado intraindividualmente para evaluar la eficacia del trasplante de melanocitos autólogos en monocapa sobre un soporte de membrana amniótica en el tratamiento del vitíligo estable. By Instituto Científico y Tecnológico de Navarra. Recruiting patients. Start date: November 2010. External link
- The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis. By National Taiwan University Hospital. Recruiting patients. Start date: May 2006. External link
- Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo. By Department of Dermatology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand. Start date: June 2009. This study is ongoing, but not recruiting participants. External link
- HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home. By Queens Medical Centre, Nottingham University Hospitals NHS Trust (United Kingdom). Start date: February 2012. This study is ongoing, but not recruiting participants. External link
- Questionnaire and Laboratory Data on Vitiligo Vulgaris. By St. Luke's-Roosevelt Hospital Center (USA). Start date: August 2010. This study is currently recruiting participants. External link
- A New Micrografting Technique for Vitiligo. By Massachusetts General Hospital (USA). Start date: September 2011. This study is currently recruiting participants. External link
- Clinical Trial of Simvastatin to Treat Generalized Vitiligo. By University of Massachusetts, Worcester (USA). Start date: January 2012. This study is currently recruiting participants. External link
Last update: April 22, 2013.
The VR Foundation cannot guarantee the completeness of this list of clinical trials. It does not contain all clinical studies conducted in the United States and elsewhere because not all studies are required by law to be registered.
For more information about clinical trials that you might be eligible for, please consult with your dermatologist. Please contact us if you are aware of additional clinical trials open to vitiligo patients.
Vitiligo Clinical Trials enrollment, by year:
|2008 -||35 trials -||Average patients recruited: 276|
|2009 -||37 trials -||Average patients recruited: 327|
|2010 -||34 trials -||Average patients recruited: 315|
|2011 -||35 trials -||Average patients recruited: 439|
|2012 -||35 trials -||Average patients recruited: 501|
Why Clinical Trials?
New to clinical trials entirely? Have you tried but it did not work for you? Continue reading »
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
May 24, 2013: VRF Presentation at EADV Spring Symposium
Sodium oxodihydroacridinylacetate in treatment of active vitiligo. Results of preliminary clinical study. Abstract and presentation here
I have vitiligo: will my children have vitiligo too?
Although most cases of vitiligo are sporadic, familial clustering is not uncommon, and up to 20% of patients report on the affected relatives. In whites, the lifetime ...
What causes vitiligo?
It remains unclear what causes damage to melanocytes and their subsequent total inactivation and/or disappearance in vitiligo skin. There are several theories; the mos...
Is it possible to stop the progression of vitiligo?
Vitiligo is progressive in 73% of cases and regressive in 1.3%. We usually explain to the patients that progression depends on the modality of the disease spreading: l...
How can I treat vitiligo?
Choosing a treatment for vitiligo can be difficult, sometimes overwhelming. In general, first-line therapy should be safe, effective, minimally invasive, and cost effi...